Inhibition of Macrophage Migration Inhibitory Factor Reduces Endometriotic Implant Size in Mice with Experimentally Induced Disease

Overview

Journal J Endometr

Date 2014 May 3

PMID 24790725

Citations 7

Authors

Warren B Nothnick

Arlene Colvin

Kai Fan Cheng

Yousef Al-Abed

Affiliations

Soon will be listed here.

Abstract

Endometriosis is a debilitating disease common in women of reproductive age characterized by pain and infertility. Macrophage migration inhibitory factor (MIF) is a cytokine whose expression is elevated in endometriotic tissue from women with the disease but the functional role of this factor in the pathogenesis of the disease is uncertain. To examine the role of MIF in the pathogenesis of endometriosis, we induced experimental disease in mice and examined the ability of the MIF antagonist, ISO-1, to reduce endometriotic implant size. Administration of ISO-1 resulted in a significant reduction in implant size and vascularity (as assessed by Flk1 mRNA expression) which was not associated with an alteration in the reproductive cycle. These data suggest that inhibition of MIF activity is associated with a significant reduction in endometriotic implant size and leads us to speculate that a similar approach of targeting MIF may prove useful in treating endometriosis in humans.

Citing Articles

Multiple lesion inductions intensify central sensitization driven by neuroinflammation in a mouse model of endometriosis.

Harvey M, Shi M, Oh Y, Mitchell D, Slayden O, MacLean 2nd J bioRxiv. 2025; .

PMID: 39896574 PMC: 11785222. DOI: 10.1101/2025.01.23.634555.

Dissecting the -Mif Pathway in Endometriosis Pathophysiology Using a Syngeneic Mouse Model: Temporal Expression of Lesion Mif Receptors, Cd74 and Cxcr4.

Nothnick W, Graham A Biomedicines. 2022; 10(7).

PMID: 35885004 PMC: 9313350. DOI: 10.3390/biomedicines10071699.

Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review.

Hung S, Zhang R, Tan Z, Chung J, Zhang T, Wang C Med Res Rev. 2021; 41(4):2489-2564.

PMID: 33948974 PMC: 8252000. DOI: 10.1002/med.21802.

Future Directions in Endometriosis Research and Therapeutics.

Nothnick W, Marsh C, Alali Z Curr Womens Health Rev. 2019; 14(2):189-194.

PMID: 31435203 PMC: 6703816. DOI: 10.2174/1573404813666161221164810.

Macrophage Migration Inhibitory Factor Receptor, CD74, is Overexpressed in Human and Baboon ( Papio Anubis) Endometriotic Lesions and Modulates Endometriotic Epithelial Cell Survival and Interleukin 8 Expression.

Nothnick W, Falcone T, Olson M, Fazleabas A, Tawfik O, Graham A Reprod Sci. 2018; 25(11):1557-1566.

PMID: 29592775 PMC: 6728574. DOI: 10.1177/1933719118766262.

References

Emonts M, Sweep F, Grebenchtchikov N, Geurts-Moespot A, Knaup M, Chanson A . Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis. Clin Infect Dis. 2007; 44(10):1321-8. DOI: 10.1086/514344. View

Kats R, Collette T, Metz C, Akoum A . Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis. Fertil Steril. 2002; 78(1):69-76. DOI: 10.1016/s0015-0282(02)03189-8. View

Greven D, Leng L, Bucala R . Autoimmune diseases: MIF as a therapeutic target. Expert Opin Ther Targets. 2010; 14(3):253-64. DOI: 10.1517/14728220903551304. View

Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R . An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med. 1999; 5(3):181-91. PMC: 2230298. View

Pelch K, Schroder A, Kimball P, Sharpe-Timms K, Davis J, Nagel S . Aberrant gene expression profile in a mouse model of endometriosis mirrors that observed in women. Fertil Steril. 2009; 93(5):1615-1627.e18. PMC: 2904074. DOI: 10.1016/j.fertnstert.2009.03.086. View

Stosic-Grujicic S, Stojanovic I, Nicoletti F . MIF in autoimmunity and novel therapeutic approaches. Autoimmun Rev. 2008; 8(3):244-9. DOI: 10.1016/j.autrev.2008.07.037. View

Yang Y, Degranpre P, Kharfi A, Akoum A . Identification of macrophage migration inhibitory factor as a potent endothelial cell growth-promoting agent released by ectopic human endometrial cells. J Clin Endocrinol Metab. 2001; 85(12):4721-7. DOI: 10.1210/jcem.85.12.7003. View

Monckedieck V, Sannecke C, Husen B, Kumbartski M, Kimmig R, Totsch M . Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model. Mol Hum Reprod. 2009; 15(10):633-43. DOI: 10.1093/molehr/gap063. View

Bruner-Tran K, Osteen K, Duleba A . Simvastatin protects against the development of endometriosis in a nude mouse model. J Clin Endocrinol Metab. 2009; 94(7):2489-94. PMC: 2708947. DOI: 10.1210/jc.2008-2802. View

10.

Barrier B . Immunology of endometriosis. Clin Obstet Gynecol. 2010; 53(2):397-402. DOI: 10.1097/GRF.0b013e3181db7c33. View

11.

Carli C, Metz C, Al-Abed Y, Naccache P, Akoum A . Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways. Endocrinology. 2009; 150(7):3128-37. PMC: 2703510. DOI: 10.1210/en.2008-1088. View

12.

Mitchell R, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J . Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A. 2002; 99(1):345-50. PMC: 117563. DOI: 10.1073/pnas.012511599. View

13.

Saito T, Mizumoto H, Kuroki K, Fujii M, Mori S, Kudo R . [Expression of MMP-3 and TIMP-1 in the endometriosis and the influence of danazol]. Nihon Sanka Fujinka Gakkai Zasshi. 1995; 47(5):495-6. View

14.

Meyer-Siegler K, Vera P, Iczkowski K, Bifulco C, Lee A, Gregersen P . Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence. Genes Immun. 2007; 8(8):646-52. DOI: 10.1038/sj.gene.6364427. View

15.

Nothnick W . Disruption of the tissue inhibitor of metalloproteinase-1 gene results in altered reproductive cyclicity and uterine morphology in reproductive-age female mice. Biol Reprod. 2000; 63(3):905-12. DOI: 10.1095/biolreprod63.3.905. View

16.

Liu D, Hitchcock A . Endometriosis: its association with retrograde menstruation, dysmenorrhoea and tubal pathology. Br J Obstet Gynaecol. 1986; 93(8):859-62. DOI: 10.1111/j.1471-0528.1986.tb07995.x. View

17.

Nishihira J, Ishibashi T, Fukushima T, Sun B, Sato Y, Todo S . Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis. Ann N Y Acad Sci. 2003; 995:171-82. DOI: 10.1111/j.1749-6632.2003.tb03220.x. View

18.

Zhang X, Hoang E, Nothnick W . Estrogen-induced uterine abnormalities in TIMP-1 deficient mice are associated with elevated plasmin activity and reduced expression of the novel uterine plasmin protease inhibitor serpinb7. Mol Reprod Dev. 2008; 76(2):160-72. PMC: 2614461. DOI: 10.1002/mrd.20938. View

19.

Veillat V, Carli C, Metz C, Al-Abed Y, Naccache P, Akoum A . Macrophage migration inhibitory factor elicits an angiogenic phenotype in human ectopic endometrial cells and triggers the production of major angiogenic factors via CD44, CD74, and MAPK signaling pathways. J Clin Endocrinol Metab. 2010; 95(12):E403-12. DOI: 10.1210/jc.2010-0417. View

20.

Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J . Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem. 2000; 275(1):444-50. DOI: 10.1074/jbc.275.1.444. View